All triptans are not the same

Journal of Headache and Pain

Volumn 2, Issue SUPPL. 1, 2001, Pages

  Rapoport, Alan M ^a,b   Tepper, Stewart J ^a,b  

^a NEW ENGLAND CENTER FOR HEADACHE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 HT1 agonist; Migraine; Triptan; Vascular headaches

Indexed keywords

ALMOTRIPTAN; CLARITHROMYCIN; ELETRIPTAN; ERYTHROMYCIN; FROVATRIPTAN; KETOCONAZOLE; MONOAMINE OXIDASE INHIBITOR; NARATRIPTAN; NEFAZODONE; PROPRANOLOL; PROTEINASE INHIBITOR; QUINIDINE; RIZATRIPTAN; SEROTONIN RECEPTOR AFFECTING AGENT; SUMATRIPTAN; TRIPTAN DERIVATIVE; UNCLASSIFIED DRUG; ZOLMITRIPTAN;

ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; CORRELATION FUNCTION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; DRUG PENETRATION; DRUG POTENTIATION; DRUG PREFERENCE; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; MALE; MIGRAINE; PHARMACOLOGICAL PARAMETERS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW;

EID: 0034786394     PISSN: 11292369     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101940170017     Document Type: Article

References (16)

1. Acute migraine therapy: The newer drugs
2. The contributions of P-glycoprotein to pharmacokinetic drug-drug interactions
3. Central sites of action are important for the antimigraine efficacy of triptan-5-HT1B/1D agonists
4. Overlapping substate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: Implications for drug delivery and activity in cancer chemotherapy
5. Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes
6. Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein
7. P-glycoprotein and cytochrome P-450 3A inhibition: Dissociation of inhibitory potencies
8. The triptans: A summary
9. Triptans in migraine: A comparative review of pharmacology, pharmacokinetics and efficacy
10. Effect of subcutaneous sumatripan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation
11. Migraine pharmacotherapy with oral triptans: A rational approach to clinical management
12. Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials
13. A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks
14. A long-term to maximize migraine relief with Zomig
15. Safety, tolerability, and efficacy of eletriptan (40 mg and 80 mg) for the long-term treatment of migraine